Marker Therapeutics, Inc. (MRKR)
NASDAQ · Healthcare
Marker Therapeutics, Inc. Revenue 2017–2025
Marker Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Marker Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 751691, a 115.32% increase year-over-year.
- Marker Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 3.2 M, a 30.50% decrease year-over-year.
- Marker Therapeutics, Inc. annual revenue for 2025 was 3.5 M, a 46.19% decrease from 2024.
- Marker Therapeutics, Inc. annual revenue for 2024 was 6.6 M, a 99.06% increase from 2023.
- Marker Therapeutics, Inc. annual revenue for 2023 was 3.3 M, a 5.76% decrease from 2022.
- Marker Therapeutics, Inc. annual revenue for 2022 was 3.5 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Marker Therapeutics, Inc. Earnings — FAQ
Marker Therapeutics, Inc. (MRKR) earnings over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRKR's earnings history?
The chart and table above show Marker Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.